CNS vs APAM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

CNS

51.9
AI Score
VS
CNS Wins

APAM

42.3
AI Score

Investment Advisor Scores

CNS

52score
Recommendation
HOLD

APAM

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS APAM Winner
Forward P/E 19.3424 9.9206 APAM
PEG Ratio 1.7705 1.38 APAM
Revenue Growth 12.2% 8.9% CNS
Earnings Growth 31.9% 18.3% CNS
Tradestie Score 51.9/100 42.3/100 CNS
Profit Margin 28.8% 24.1% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -11.6% · 3M: -1.4% APAM 1M: -9.3% · 3M: +6.8%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.6 · Price: $74.95

APAM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $37.91

Fundamentals Snapshot

Metric CNS APAM
Market Cap
Forward P/E 18.8 9.6
Trailing P/E 23.7 9.6
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.3% 0.3%
EPS 3.23 4.12
Dividend Yield 0.03% 0.09%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.